References
- Lindpaintner K., Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 1991; 68: 905–921
- Tanaka K., Honda M., Kuramochi T., Hashimoto M., Masumura S., Mansoor A. M., Ishikawa S., Morioka S. Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy. J Hypertens 1994; 12: 1147–1154
- Mohabir R., Young S. D., Strosberg A. M. Role of angiotensin in pressure overload induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an At1 receptor antagonist, and surgical reversal. J Cardiovasc Pharmacol 1994; 23: 292–299
- Clozel J. P., Saunier C., Hartemann D., Fischli W. Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia. J Cardiovasc Pharmacol 1991; 17: 36–40
- Zierhut W., Zimmer H. G., Gerdes A. M. Influence of ramipril on right ventricular hypertrophy induced by pulmonary artery stenosis in rats. J Cardiovasc Pharmacol 1990; 16: 480–486
- Timmermans P. B., Wong P. C., Chiu A. T., Herblin W. F., Benfield P., Carini D. J., Lee R. J., Wexler R. R., Saye J. A., Smith R D. Angiotensin II receptors and angiotensin II antagonists. Pharmacol. Rev 1993; 45: 205–251
- Bader M., Zhao Y., Sander M., Lee M. A., Bachmann J., Böhm M., Djavidani B., Peters J., Mullins J. J., Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 1992; 19: 681–686
- Stinger R. B., Iacopino V. J., Alter I., Fitzpatrick T. M., Rose J. C., Kot P. A. Catheterization of the pulmonary artery in the closed-chested rat. J Appl Physiol 1981; 51: 1047–1050
- Hermann K., Lang R. E., Unger T., Bayer C., Ganten D. Combined high-perfomance liquid chromatography-radioimmunoassay for the characterization and quantitative measurement of neuropeptides. J Chromatograhpy 1984; 312: 273–284
- Unger T., Schüll B., Rascher W., Lang R. E., Ganten D. Selective activation of the converting-enzyme Inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol 1982; 31: 3063–3070
- Salvaterra C. G., Rubin L. J. Cardiovascular effects of pulmonary hypertension. Trends Cardiovasc Med 1991; 1: 65–69
- Johnston C I. Hypertension. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994; 23: 258–268
- Cassis L. A., Rippertoe P. E., Soltis E. E., Painter D. J., Fitz R., Gillespie M. N. Angiotensin II and monocrotaline-induced pulmonary hypertension:effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptof antagonist. J Pharmacol Exp Ther 1992; 262: 1168–1172
- Schunkert H., Dzau V. J., Tang S. S., Hirsch A. T., Apstein C. S., Lorell B. H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 1990; 86: 1913–1920
- Schunkert H., Ingelfinger J. R., Hirsch A. T., Pinto Y., Remme W. J., Jacob H., Dzau V. J. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993; 72: 312–318